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TestisTCAM1P is a unitary pseudogene, which was disabled since the human–mouse divergence. Here we
found that TCAM1Pwas speciﬁcally expressed in the human testis, with different cell type-speciﬁcity
from mouse Tcam1, and characterized its transcripts. At the mouse locus, a multifunctional dual
promoter–enhancer (DPE) controls the expression of Tcam1 and Smarcd2 genes. The corresponding
human sequence was found to potentially function as a DPE, although the molecular mechanism
was different from mouse. Interestingly, the change in DPE activity occurred before pseudogeniza-
tion of TCAM1P. These data suggest the presence of a DPE in the human genome for the ﬁrst time,
and provide an important model of evolutionary changes in the regulatory mechanism of a
pseudogene.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Functions and expression patterns of orthologous genes are
generally conserved between closely related species [1,2], but it
is not the case for pseudogenes. Pseudogenes have lost their
original functions in the process of evolution, and are silenced or
expressed as non-coding RNAs, sometimes with different patterns
from their ancestral genes [3]. Recently, some of the transcribed
pseudogenes were revealed to be functional and have novel roles
[4–6]. Thus, it is of great importance to have a better understand-
ing of pseudogenes, but many issues remain to be resolved.Especially, regulatory mechanisms of pseudogenes are largely
unknown.
We previously investigated a regulatory mechanism at the
mouse testicular cell adhesion molecule 1 (Tcam1) gene locus, and
identiﬁed mouse conserved non-coding sequence 1 (mCNS1) as a
multifunctional dual promoter–enhancer (DPE) [7]. mCNS1 could
function as a spermatocyte-speciﬁc enhancer for Tcam1 and a bidi-
rectional promoter of the SWI/SNF-related, matrix-associated, actin-
dependent regulator of chromatin, subfamily d, member 2 (Smarcd2)
gene and a testis-speciﬁc long non-coding RNA (lncRNA), lncRNA-
Tcam1 [7]. This was the ﬁrst indication of a DPE in mammals,
although two examples had been reported in chicken [8,9].
Interestingly, while the synteny of Smarcd2 and Tcam1 genes is
conserved among eutherians, a human orthologue of Tcam1,
TCAM1P, is considered to be a pseudogene [10], albeit mouse Tcam1
encodes a cell adhesion protein [11]. TCAM1P was pseudogenized
since the human–mouse divergence [10], and therefore, it is of sig-
niﬁcance to note whether expression patterns and regulatory
mechanisms at the human TCAM1P locus are conserved or not.
The mechanisms are also notable in terms of the gene regulation
by multifunctional genomic elements, because the TCAM1P gene
is linked to the human growth hormone (hGH) gene cluster, a
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tional elements [12–16].
In this study, we investigated the expression and regulation of
human TCAM1P and SMARCD2 genes. Our results indicated that
the expression pattern of TCAM1P was slightly different from
mouse Tcam1, and that human CNS1 (hCNS1) could function as a
DPE, although the molecular mechanism was different from
mCNS1. The data provide the ﬁrst evidence for the presence of
DPE in human genome, and represent an important model for gene
regulatory mechanisms before and after pseudogenization.
2. Materials and methods
2.1. RNA analyses
Total RNAs from the human liver and testis were purchased
from Clontech Laboratories, Inc. (Mountain View, USA) and reverse
transcription-polymerase chain reaction (RT-PCR) was done as pre-
viously described [17]. Primer sequences are shown in Table 1. The
primer pair for b-ACTIN was used by another group [18].
2.2. Rapid ampliﬁcation of cDNA ends (RACE)
50RACE and 30RACE were performed as previously described
[7,17]. All the ampliﬁed products were subcloned into a pBlue-
script vector (Stratagene, La Jolla, CA) by the TA-cloning method,Table 1
Oligonucleotide primers used in this study.
Designation Forward
RT-PCR
TCAM1P P3 50-TTCTGTTTGGTGTCTGGACC-30
lncRNA-TCAM1P 50-CTCCGGGATTTCCTAATCCA-30
1 50-CCCTCTGATGGTCTGGATCT-30
2 50-CCCTCCCATCCCTGTAAAGT-30
3 50-GCCTCTCTGTTCTCTCACAC-30
4 50-TCTCCCTTGATCCCTGTTGT-30
5 50-CCACCGATTTTTGGTAGCTG-30
6 50-GAAGGACTGGATGCCAAGA-30
b-ACTIN 50-AAGAGAGGCATCCTCACCCT-30
50RACE
AAP 50-GGCCACGCGTCGACTAGTACGG
AUAP 50-GGCCACGCGTCGACTAGTAC-30
TCAM1P RT-1
TCAM1P GSP1-1
TCAM1P GSP2-1
TCAM1P RT-2
TCAM1P GSP1-2
TCAM1P GSP2-2
lncRNA-TCAM1P RT
lncRNA-TCAM1P GSP1
lncRNA-TCAM1P GSP2
lncTCAM1P-6.1kb RT3
lncTCAM1P-6.1kb GSP1-3
lncTCAM1P-6.1kb GSP2-3
lncTCAM1P-5.3kb RT4
lncTCAM1P-5.3kb GSP1-4
lncTCAM1P-5.3kb GSP2-4
30RACE
AP
TCAM1P GSP3-1 50-TTCTGTTTGGTGTCTGGACC-30
TCAM1P GSP4-1 50-GATTCAAAAGGACACAAGCC-30
lncRNA-TCAM1P GSP3 50-CCACACTCCCCGAAAATAGT-30
lncRNA-TCAM1P GSP4 50-AAAGACTCAGCTGCTCTGTG-30
lncTCAM1P-6.1kb GSP3-2 50-AGTGGAGAATCAGAGTCCTC-30
lncTCAM1P-6.1kb GSP4-2 50-GGTCGCATCAGAAAACACAA-30
Reporter constructs
TCAM1P Promoter 50-CAGCACAGACTCTGGGAATT-30
hCNS1 ﬁrst 50-AGTTCCTCATGCATTCCCCA-30
hCNS1 nested 50-CTCCGGGATTTCCTAATCCA-30and at least 10 subclones were sequenced for each product. All
the primer sequences used for these analyses are listed in Table 1.
2.3. Reporter constructs
A promoter region of the TCAM1P gene was ampliﬁed by PCR
using KOD FX (Toyobo, Osaka, Japan) with human sperm genomic
DNA (Clontech Laboratories, Inc.) and a primer pair listed in Table 1.
The 2012-bp product was ligated to upstream of the luciferase gene
in a pGL3-Basic vector (Promega Corporation, Madison, WI) at the
SmaI site, and we named the resulting construct TCAM1P-Pro-luc.
To obtain the hCNS1 sequence, we had to perform two rounds of
PCR reactions, presumably due to the high GC content of the region
encompassing hCNS1. The ﬁrst round PCR was performed by KOD
FX (Toyobo) with human genomic DNA using the ‘hCNS1 ﬁrst’ pri-
mer pair (Table 1), and the 1340-bp product was puriﬁed and used
as a template for the second PCR with the ‘hCNS1 nested’ primer
pair (Table 1). By inserting the 450-bp product into the blunted NheI
site of TCAM1P-Pro-luc, we obtained the hCNS1-Pro-luc construct.
To generate the Pro-luc-hCNS1 and Pro-luc-reversed (rev) hCNS1
constructs, we cloned the hCNS1 fragment into the blunted BamHI
site of TCAM1P-Pro-luc. To linearize the constructs, we digested
them by SalI. The hCNS1-luc and rev hCNS1-luc constructs were
generated by inserting the hCNS1 sequence into the SmaI site of a
pGL3-Basic vector. All the constructs were subject to the sequencing
analysis prior to transfection studies.Reverse
50-GGGTACATGACACTTCACTG-30
50-GGGAGGTTTCTCATAAGCCA-30
50-TAGCTTGCCCCTTTTCTAGG-30
50-AGAAAAAGATCCTGCCTTCG-30
50-CCTCCCACTACACTCAAACA-30
50-GGGAATATTGCCTCCACTTC-30
50-AGCTGGGACAGGCTCTGATA-30
50-CGGCTGTATGAGGAAAACAA-30
50-TACATGGCTGGGGTGTTGAA-30
GIIGGGIIGGGIIG-30
50-GGGTACATGACACTTCACTG-30
50-TCCAGACACCAAACAGAAGC-30
50-CTGATAAGAAGGGCCAAAGG-30
50-AAGCACTGCAGGATGGAA-30
50-CTTTGCCCACCTGAGTTTTC-30
50-TCCAGACACCAAACAGAAGC-30
50-AACCGGGTCTGTGAGGAACT-30
50-CTGTGAGGAACTCGCGAACT-30
50-TGGATTAGGAAATCCCGGAG-30
50-CAGGAGGTAAGAAAACAGCA-30
50-GTGCTATGATGCAAGGAAGG-30
50-TTACTTGGTTGGGGCTGGAA-30
50-TAGCTTGCCCCTTTTCTAGG-30
50-CGGAGGTATTTTGGAGTAGC-30
50-ACTTTACAGGGATGGGAGGG-30
50-CTGATCTAGAGGTACCGGATCC-30
50-TGAATGCACGAACCAACGCA-30
50-GTTGAGTTGGCTGCTGTTCT-30
50-AGAGAGTAGTAGCAACGGCT-30
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Fig. 1. Ubiquitous distribution of SMARCD2 mRNA and testis-speciﬁc expression of
TCAM1PmRNA in human tissues. (A) Expression of SMARCD2 and TCAM1PmRNAs in
eleven human tissues were searched on IGV. Transcript signals were indicated as
blue bars and exon–intron structures of these genes are depicted at the bottom. The
signals were observed in all eleven tissues at the SMARCD2 gene, while those at the
TCAM1P locus were mostly present in the testis. (B) Putative seven transcripts of the
human TCAM1P gene are shown according to the Ensembl database. We searched
for the database when we started this study in 2009. The predicted TCAM1P gene
consisted of 8 exons. To distinguish the seven transcripts, RT-PCR was performed
using four primer pairs whose positions are indicated by arrows (P1, P2, P3, and P4).
cDNAs were prepared by reverse transcription with the oligo(dT) primer using
testis and liver total RNAs. By PCR reactions, speciﬁc signals were ampliﬁed only
with P3. The ampliﬁed exons were painted with red, and the transcripts were
named TCAM1P-I, TCAM1P-II, and TCAM1P-III. (C) The result of RT-PCR using a
primer pair, P3, and human testis and liver RNAs is shown. Three transcripts were
detected at different positions only in the testis. b-ACTIN was ampliﬁed as an
internal control.
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GC-2spd(ts), Hepa1-6, and HEK293T cells were cultured in Dul-
becco’s modiﬁed Eagle’s medium containing 10% fetal bovine
serum, 100 U/ml penicillin, 100 lg/ml streptomycin, and 292 lg/
ml L-glutamine (Invitrogen, Carlsbad, CA). The reporter gene assay
was performed as previously described [7,19].
2.5. Statistical analysis
The results were expressed as means ± S.D. One-way analysis of
variance (ANOVA) followed by Tukey–Kramer’s test was performed
using Microsoft Excel statistical analysis functions (Microsoft
Corp., Redmond, WA). P < 0.05 was considered statistically
signiﬁcant.
3. Results
3.1. Tissue distribution of human SMARCD2 and TCAM1P mRNAs
We ﬁrst investigated the tissue-speciﬁcity of human SMARCD2
and TCAM1P genes by searching for the next generation sequencing
data on Integrative Genomics Viewer (IGV) (http://www.broadin-
stitute.org/igv). Transcript signals at the TCAM1P gene were most
abundantly present in the testis among eleven human tissues,
while signiﬁcant levels were observed at the SMARCD2 gene in
all the tissues (Fig. 1A). To know what types of cells expressed
TCAM1PmRNA in the human testis, we referred to microarray data
of fractionated testicular germ cells and of the whole testis from
patients whose spermatogenesis was arrested at various stages.
Both data showed that TCAM1P mRNA was exclusively expressed
in germ cells, mainly in spermatocytes, but weak signals were also
detected in spermatogonia and spermatids [20,21]. These indicated
that the cell type-speciﬁcity of human TCAM1P was different from
mouse Tcam1 which was expressed only in spermatocytes [7,11].
Because the TCAM1P gene was considered to be a pseudogene,
we next investigated what kinds of transcripts were actually tran-
scribed. According to the Ensembl database (http://www.ensembl.
org/index.html), seven transcripts were transcribed from the
TCAM1P gene as shown in Fig. 1B. To distinguish these transcripts,
we designed four primer sets (Fig. 1B, P1–P4) and performed RT-
PCR with human testis and liver RNAs. As a result, we could not
amplify any speciﬁc products with P1, P2, and P4 in either tissue,
but detected three speciﬁc bands in the testis with P3 (data not
shown, Fig. 1C). We named the detected transcripts, TCAM1P-I,
TCAM1P-II, and TCAM1P-III (Fig. 1B and C).
3.2. Determination of full-length sequences of TCAM1P transcripts
To determine full-length sequences of the three TCAM1P tran-
scripts, we conducted 50RACE and 30RACE analyses using the
human testis RNA. 50RACE was performed with two primer sets:
one for detecting the transcriptional start site (TSS) of TCAM1P-I
and TCAM1P-III (Fig. 2B), and the other for TSS of TCAM1P-I and
TCAM1P-II (Fig. 2C). We identiﬁed one nucleotide at the position
+401, which was 401 bp downstream of TSS in the Ensembl data-
base (Fig. 2A and B), as TSS of TCAM1P-I and TCAM1P-III (Fig. 2B).
In contrast, we found ﬁve different TSSs of TCAM1P-I and
TCAM1P-II, each of which was positioned at +494, +401, +377,
+329, and +5100 (Fig. 2C). The nucleotide at +401 might be derived
from TCAM1P-I. These results indicated that there was one TSS of
TCAM1P-I and TCAM1P-III at +401, and TCAM1P-II had at least four
TSSs.
30RACE was performed using a primer set that could detect the
transcriptional termination site (TTS) of all the transcripts. TwoTTSs were identiﬁed at the position of +10555 and +10837
(Fig. 2D). Because 8 out of 10 subclones contained the nucleotide
at +10837 as TTS, it was considered to be a major TTS. To see
whether all the three transcripts were actually terminated at the
major TTS, we conducted RT-PCR by using a primer at the ﬁnal
exon for reverse transcription and a primer pair speciﬁc to each
transcript for PCR. As a result, a speciﬁc signal was observed for
each of the three transcripts (data not shown), which indicated
that all the TCAM1P transcripts contained +10837 as their TTSs.
We also examined whether the three transcripts were terminated
(A)
(B)
(C)
(D)
(E)
Fig. 2. Determination of 50 and 30 ends of TCAM1P transcripts. (A) The human
TCAM1P gene structure based on the Ensembl database is shown at the top with
gray boxes. The actual exon–intron structure determined in this study is shown
below with black boxes. Exon numbers of the actual TCAM1P gene is indicated as
Ex1–Ex5. The ﬁrst nucleotide of exon 1 in the database is designated as +1 in this
ﬁgure. (B) 50RACE was performed to determine TSS of TCAM1P-I and TCAM1P-III
transcripts. cDNA was prepared with the human testis total RNA by reverse
transcription using a primer, RT-1. The ﬁrst and second PCR reactions were
performed using GSP1-1 and GSP2-1, respectively. After subcloning of the product,
10 subclones were sequenced, and a single TSS was determined at the position of
+401. (C) 50RACE was performed for TSS of TCAM1P-I and TCAM1P-II transcripts as in
(B) by using RT-2 for reverse transcription, and GSP1-2 and GSP2-2 primers for two
rounds of PCRs. After subcloning, 29 subclones were sequenced, and ﬁve different
TSSs were detected as indicated. The number of subclone, which contained each
position as TSS, is shown at the right side of each structure. (D) 30RACE was
performed to determine TTS of TCAM1P-I, TCAM1P-II, and TCAM1P-III. cDNA was
prepared with the human testis total RNA by reverse transcription with the
oligo(dT) primer connected to an adaptor sequence. The ﬁrst and second PCR
reactions were performed with GSP3-1 and GSP4-1 primers, respectively. After
subcloning, 10 subclones were sequenced, and 8 of them contained the position of
+10837 as TTS. The other 2 subclones were terminated at +10555. (E) Structures of
human TCAM1P transcripts determined in this study. RACE analyses revealed that
TCAM1P-II had at least four TSSs and a single TTS, and TCAM1P-I and TCAM1P-III had
a single TSS and a single TTS. Consequently, six TCAM1P transcripts were expressed
in the human testis. Nucleotide sequence data for the six TCAM1P transcripts are
available in DDBJ/EMBL/GenBank databases under the accession numbers
LC005096 (TCAM1P-I), LC005097 (TCAM1P-IIa), LC005098 (TCAM1P-IIb), LC005099
(TCAM1P-IIc), LC005100 (TCAM1P-IId), and LC005101 (TCAM1P-III).
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Taken together, TCAM1P-II had at least four TSSs and one TTS,
and TCAM1P-I and TCAM1P-III had one TSS and one TTS. Therefore,
we concluded that at least six TCAM1P transcripts were present in
the human testis as shown in Fig. 2E, and that the TCAM1P gene
was actually composed of ﬁve exons (Fig. 2A).
Although the Tcam1 gene in rodents and rhesus monkey
encodes a protein related to a cell adhesion molecule, the human
TCAM1P gene is considered to be a pseudogene [10]. Since we
determined full-length sequences of six TCAM1P transcripts, wesearched for their open reading frames (ORFs). The maximum ORFs
predicted from the nucleotide sequences were 99, 58, and 49
amino acids for TCAM1P-I, TCAM1P-II, and TCAM1P-III, respectively.
However, amino acid sequences of those ORFs showed no homol-
ogy to the mouse TCAM1 protein. Therefore, the human TCAM1P
gene could be non-coding RNAs or could encode polypeptides that
were not related to the TCAM1 protein of other species.
3.3. Enhancer and promoter activity of hCNS1
We then investigated a regulatory mechanism at the human
SMARCD2-TCAM1P locus by examining whether hCNS1 could func-
tion as a DPE similarly to mCNS1.
We ﬁrst investigated enhancer activity of hCNS1. Because TSS of
TCAM1P-I and TCAM1P-III was +401 and three TSSs of TCAM1P-II
were close to +401 (Fig. 2E), we cloned about 2-kb sequence
upstream of +401 as a major promoter of the TCAM1P gene and
connected it to the luciferase gene (TCAM1P-Pro-luc). hCNS1 was
ampliﬁed by genome PCR and cloned to upstream of the TCAM1P
promoter (hCNS1-Pro-luc) or to downstream of the luciferase gene
(Pro-luc-hCNS1 and Pro-luc-rev hCNS1). Enhancer activity of
hCNS1 was assessed by reporter gene assay with three cell lines,
GC2-spd(ts), Hepa1-6, and HEK293T, which were derived from
mouse spermatocytes, mouse hepatocytes, and human embryonic
kidney, respectively.
The activity of hCNS1-Pro-luc was signiﬁcantly increased in all
three cell lines compared to the construct without hCNS1 (Fig. 3A).
When we connected hCNS1 to 30 of the luciferase gene, the activity
was also signiﬁcantly increased in all cells irrespective of its orien-
tation (Fig. 3A). Fold-increases were 1.8–3.5 in most experiments,
but a 4.5-fold increase was observed in GC-2spd(ts) cells when
hCNS1 was connected to 30 of the luciferase gene in forward orien-
tation (Fig. 3A, Pro-luc-hCNS1). We do not know the reason for the
variable activity, but there were several reports of enhancers
showing different activity depending on its position or direction
by reporter gene assay [22–25].
We also examined the luciferase activity in linearized
constructs. If hCNS1 was actually a DPE, it might drive the tran-
scription of the entire sequence in a circular plasmid, which might
affect the luciferase gene expression. To prevent hCNS1 from
driving the luciferase gene transcription in the sense direction,
we linearized Pro-luc-hCNS1 and Pro-luc-rev hCNS1 constructs
by cutting the immediate downstream sequence of hCNS1 and
rev hCNS1. As a result, hCNS1 still signiﬁcantly increased TCAM1P
promoter activity in HEK293T cells, and the fold-increases were
around 3 in both constructs compared to the linearized TCAM1P-
Pro-luc construct (Fig. 3B). These data showed that hCNS1 could
function as an enhancer for the TCAM1P gene.
We next investigated whether hCNS1 had promoter activity or
not. Since hCNS1 encompassed exon 1 and an upstream region of
SMARCD2, it was regarded as a promoter of SMRACD2. To assess
the promoter activity of hCNS1, we connected it directly to the
luciferase gene in both orientations (Fig. 4). By reporter gene assay,
hCNS1 showed promoter activity in both directions, but the activ-
ity was stronger in the reverse direction in all the cell lines (Fig. 4).
This indicated that hCNS1 had bidirectional promoter activity, but
the activity was stronger for the SMARCD2 gene.
3.4. Intergenic transcription at the human SMARCD2-TCAM1P locus
At the mouse Smarcd2-Tcam1 locus, mCNS1 can drive not only
Smarcd2 but also lncRNA-Tcam1 [7]. Because hCNS1 showed bidi-
rectional promoter activity by reporter gene assay (Fig. 4), we
assessed the possibility that hCNS1 could be a promoter for an
lncRNA as well as SMARCD2. We performed RT-PCR with the
human testis RNA and successfully ampliﬁed the hCNS2 sequence
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Fig. 3. Enhancer activity of hCNS1 by in vitro reporter gene analysis. (A) Reporter
gene constructs were generated as indicated at the left side of the graph. The
constructs were transfected into GC-2spd(ts) (pink bar), Hepa1-6 (yellow bar), or
HEK293T cells (blue bar) by GeneJuice transfection reagent (Novagen Inc., USA), and
luciferase activity was measured two days later. The construct without any
promoter for the luciferase gene was used for a comparison and the luciferase
activity of this construct was set to 1.0. TCAM1P promoter activity was enhanced by
hCNS1 in all three cell lines irrespective of its position and orientation. The data are
presented as mean ± S.D. from at least six independent experiments. n = 6–18.
⁄⁄P < 0.01 relative to TCAM1P-Pro-luc construct, one-way ANOVA followed by
Tukey–Kramer’s test. (B) Enhancer activity of hCNS1 was assessed in linearized
constructs. The indicated constructs were linearized by digestion with SalI and
transfected into HEK293T cells. hCNS1 signiﬁcantly enhanced TCAM1P promoter
activity. The data are presented as mean ± S.D. from six independent experiments.
n = 6. ⁄⁄P < 0.01 relative to linearized TCAM1P-Pro-luc construct, one-way ANOVA
followed by Tukey–Kramer’s test.
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Fig. 4. Bidirectional promoter activity of hCNS1 by reporter gene assay. hCNS1 was
connected directly to the luciferase gene in both directions, and the reporter gene
assay was performed as in Fig. 3 using GC-2spd(ts), Hepa1-6, and HEK293T cells.
The data are presented as mean ± S.D. from six independent experiments. n = 6.
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Fig. 5. Intergenic transcription between SAMRCD2 and TCAM1P genes. (A) A
schematic drawing of the 50 upstream region of the TCAM1P gene. Exons 1 and 2
of the SMARCD2 gene and exon 1 of the TCAM1P gene (determined in this study) are
depicted with white and black rectangles, and arrows indicate their transcriptional
directions. Positions of three CNSs (hCNS1, hCNS2, and hCNS3) are shown. A full-
length 1.1-kb transcript, lncRNA-TCAM1P, and six amplicons are indicated by blue
and black lines, respectively. TSS and TTS of lncRNA-TCAM1P were determined to be
positioned at 7023 bp and 5549 bp relative to TSS of TCAM1P by 50RACE and
30RACE. In each analysis, all 10 subclones contained the same nucleotide as TSS or
TTS. (B) Expression of intergenic regions at the SMARCD2-TCAM1P locus by RT-PCR.
PCR reactions were conducted for six amplicons indicated in (A) and for lncRNA-
TCAM1P. A speciﬁc signal was detected for all the amplicons in the testis, but not in
the liver. Because we used the same cDNAs as in Fig. 1C, an internal control should
be referred to Fig. 1C. (C) Cloning of the full-length sequence of lncTCAM1P-6.1kb.
The structure of the locus is drawn as in (A). 50 and 30 ends of the transcript from
amplicon 1 were determined by 50RACE and 30RACE. 50RACE was performed with
RT-3 for reverse transcription and GSP1-3 and GSP2-3 for two rounds of PCRs. After
subcloning of the product, 13 subclones were sequenced, and three different TSSs
were detected as indicated. For 30RACE, GSP3-2 and GSP4-2 were used for two
rounds of PCRs, and we detected three TTSs by sequencing 12 subclones as
indicated. A full-length of the major transcript for lncTCAM1P-6.1kb is depicted at
the top. (D) Determination of TSSs of lncTCAM1P-5.3kb. 50RACE was performed using
RT-4 for reverse transcription and GSP1-4 and GSP2-4 for PCRs. By sequencing 11
subclones, two TSSs were determined as indicated. Data for full-length sequences of
lncRNA-TCAM1P and lncTCAM1P-6.1kb and a partial sequence of lncTCAM1P-5.3kb
are available in DDBJ/EMBL/GenBank databases under the accession numbers
LC005102, LC019129, and LC019128, respectively.
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determine the full-length sequence of the transcript, we performed
50RACE and 30RACE analyses. By sequencing 10 subclones each for
50RACE and 30RACE, we detected a single TSS and a single TTS (data
not shown). Consequently, we identiﬁed a 1.1-kb transcript includ-
ing one intron (Fig. 5A) and named it lncRNA-TCAM1P, because it
was classiﬁed as an lncRNA by the coding potential calculator
[26]. However, the lncRNA-TCAM1P promoter region did not over-
lap with hCNS1 (Fig. 5A), which indicated that hCNS1 was not a
promoter for lncRNA-TCAM1P.We then investigated the possible presence of other transcripts
from the intergenic region between SMARCD2 and TCAM1P genes.
By RT-PCR with six primer pairs (Fig. 5A, 1–6) and human testis
and liver RNAs, we detected speciﬁc signals from all the examined
regions in the testis, but not in the liver (Fig. 5B). This indicated
that, consistent with Fig. 1A, most of the intergenic region between
SMARCD2 and TCAM1P genes were speciﬁcally transcribed in the
testis.
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attempted to determine full-length sequences of the transcripts
from amplicons 1 and 2. However, because approximately 70%
sequence from 30 end of amplicon 2 overlapped with repeat
sequences, we performed 50RACE only for this transcript, while
both ends were determined for amplicon 1. As a result, we
detected three TSSs and three TTSs for amplicon 1, and two TSSs
for amplicon 2 (Fig. 5C and D). Judging from the number of sub-
clones, a major TSS was presumed to be the nucleotide at
6124 bp and 5339 bp relative to TSS of TCAM1P for amplicons
1 and 2, respectively, and a major TTS for amplicon 1 was posi-
tioned at 4563 bp (Fig. 5C and D). Collectively, we identiﬁed
two novel lncRNAs: a full-length sequence of lncTCAM1P-6.1kb
(Fig. 5C) and a partial sequence of lncTCAM1P-5.3kb (Fig. 5D). These
transcripts were conﬁrmed to be transcribed as single transcripts
by RT-PCR performed as described in Section 3.2 (data not shown).
As pointed out by many researchers [27,28], it was difﬁcult to
directly align the human lncRNAs we detected with mouse
lncRNA-Tcam1, but they might be functionally homologous. What
is important is that promoters of lncTCAM1P-6.1kb and lncT-
CAM1P-5.3kb did not overlap with hCNS1, which indicated that
hCNS1 could not be promoters of these lncRNAs. The data suggest
that hCNS1 may be a unidirectional promoter, although we cannot
completely rule out the possibility that it functions bidirectionally.
3.5. Changes of CNS1 activity before pseudogenization of TCAM1P
The above data revealed the functional difference between
mCNS1 and hCNS1, and we ﬁnally investigated how CNS1 activity
was changed during evolution. Zhang et al. demonstrated that
TCAM1P was pseudogenized at the gorilla-chimpanzee divergence
by comparing genomic sequences from several primate species
[10], and we examined the evolutionary change in CNS1. We
collected CNS1 sequences from mouse, rat, an old world monkey
(rhesus monkey), an ape (gibbon), and human by searching for
the Ensembl and NCBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi) dat-
abases, and compared each sequence with another. As a result,
hCNS1 shared more than 90% nucleotide identity with CNS1 of rhe-
sus monkey and gibbon, in contrast to less than 80% with that of
rodents (Fig. 6A). Conversely, mCNS1 showed 93% nucleotide iden-
tity with rat CNS1, but had less than 80% with other species
(Fig. 6A). In addition, we could not ﬁnd any nucleotides in CNS1
that were changed only in human and conserved in the other four
species to allow hCNS1 to possess a speciﬁc function to human
(Fig. 6B). Therefore, CNS1 is presumed to be functionally changed
before pseudogenization of TCAM1P, which suggests that cell-type
speciﬁcity of the TCAM1 gene was altered before the
pseudogenization.
4. Discussion
4.1. hCNS1 is a potential DPE
One aim of this study was to determine whether human gen-
ome contained a DPE, and we assessed enhancer activity of hCNS1.
Although all the constructs containing hCNS1 increased TCAM1P
promoter activity (Fig. 3), the strong promoter activity of hCNS1
might affect the luciferase gene expression. Even in the assay with
linearized constructs, hCNS1 and rev hCNS1 might drive the tran-
scription of the luciferase gene in the antisense direction, which
might affect the luciferase expression. However, because the pro-
moter activity of hCNS1 was orientation-dependent (Fig. 4), the
antisense transcription would affect the luciferase activity to
different extents in the Pro-luc-hCNS1 and Pro-luc-rev hCNS1 con-
structs. Nonetheless, the activity in these constructs was similar(Fig. 3B), which indicated that the antisense transcription was
unlikely to affect the luciferase gene expression. Therefore, we con-
clude that hCNS1 is a potential enhancer for TCAM1P similarly to
mCNS1.
Interestingly, a mechanism underlying the enhancer activity
seemed to be different, because hCNS1 enhancer activity was
observed in all the cell lines we examined (Fig. 3), whereas mCNS1
enhancer activity was speciﬁc to spermatocyte-derived GC-
2spd(ts) cells [7]. This indicates that different transcription factors
function in different nucleotides between mCNS1 and hCNS1. In
the human testis, a transcription factor common to various cell
types may bind to hCNS1 and up-regulate the TCAM1P expression.
In this case, the testis-speciﬁc TCAM1P gene activation may be con-
trolled by the epigenetic state or by other cis-/trans-elements.
hCNS1 also showed bidirectional promoter activity, but the
activity was stronger for SMARCD2 than for the opposite direction
(Fig. 4). This is in contrast to mCNS1, whose promoter activity in
each direction was similar [7]. Because we failed to detect any
transcripts driven by hCNS1 extending to the opposite direction
of SMARCD2 (Fig. 5), hCNS1 may be a unidirectional promoter.
However, hCNS1 promoter activity opposite to SMARCD2 was still
much higher than that of TCAM1P promoter (Fig. 4), and there were
transcripts, other than the three lncRNAs we identiﬁed, transcribed
from the intergenic region between SMARCD2 and TCAM1P genes
(Figs. 1A and 5). Further analysis will be necessary to reveal
whether hCNS1 is a bidirectional promoter or not, but our data
clearly indicate that hCNS1 is at least a promoter of the SMARCD2
gene.
Taken together, hCNS1 could enhance TCAM1P promoter activ-
ity and functioned as a promoter of the SMARCD2 gene. Therefore,
similarly to mCNS1, hCNS1 can be a DPE in the human testis.
4.2. Evolutionary changes in parallel with pseudogenization
Another aim of this work was to determine evolutionary
changes, especially in gene regulatory mechanisms, in light of the
pseudogenization of the human TCAM1P gene. Pseudogenes are
generally classiﬁed as unitary, duplicated, and retrotransposed
pseudogenes, which were generated by spontaneous mutations
in a single copy gene, duplication of a genomic region, and retro-
transposition of processed mRNAs into other genomic regions,
respectively [29]. TCAM1P is a unitary pseudogene [10], and it is
possible to directly compare the human TCAM1P locus with the
mouse one.
In both human and mouse, we conﬁrmed ubiquitous Smarcd2/
SMARCD2 expression and DPE activity of mCNS1/hCNS1, but other-
wise, many differences were found by our analyses. Firstly, human
TCAM1P was testis-speciﬁc, but the cell type expressing it was not
only spermatocytes but also spermatogonia and spermatids,
whereas mouse Tcam1 mRNA was speciﬁc to spermatocytes
[7,20,21]. Secondly, functions of TCAM1P and Tcam1 are obviously
different. TCAM1P does not encode a cell adhesion molecule, and
instead, encodes smaller peptides or functions as lncRNAs. Thirdly,
hCNS1 showed enhancer activity in more cell types than mCNS1,
indicating different molecular mechanisms between these two
species as discussed above. Fourthly, hCNS1 enhancer activity
was lower than mCNS1. By reporter gene assay, mCNS1 mostly
showed about 5-fold higher activity than Tcam1 promoter [7],
while the activity of hCNS1 was 1.8–4.5-fold higher than TCAM1P
promoter (Fig. 3). Fifthly, hCNS1 may not be a bidirectional pro-
moter as discussed above. Finally, more lncRNAs were transcribed
at the human locus. These indicates that the expression of TCAM1P
and lncRNAs was changed during evolution, and that the gene reg-
ulation at this locus, especially the molecular mechanism underly-
ing DPE activity, was also changed.
Fig. 6. Comparison of CNS1 sequences from ﬁve mammalian species. (A) Nucleotide identities (%) between CNS1 sequences from the indicated species. The CNS1 sequences
were obtained from Homo sapiens (human), Nomascus leucogenys (gibbon), Macaca mulatta (rhesus monkey), Rattus norvegicus (rat), and Mus musculus (mouse) by searching
for the Ensembl and NCBI databases, and each sequence was compared with another. (B) A multiple alignment of the CNS1 sequences from ﬁve mammalian species. The CNS1
sequences from the indicated species were compared using the DNASIS-Pro software (HITACHI Software Engineering, Yokohama, Japan). Conserved nucleotides among four
or ﬁve species are shaded.
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pseudogenization of the TCAM1P gene. This suggests that the
TCAM1 gene is expressed in spermatogonia, spermatocytes, and
spermatids not only in human but also in rhesus monkey and gib-
bon that contain the protein-coding TCAM1 gene. If this is the case,
the cell adhesion protein may be necessary in the three types of
germ cells during meiosis in rhesus monkey and gibbon, but
unnecessary in chimpanzee and human. Considering that Tcam1-
knockout mice were normal [11] and the function of TCAM1 as a
cell adhesion molecule is probably redundant, the TCAM1P pseudo-
gene might gain a new role in chimpanzee and human. In this
context, it is of note that human TCAM1P, together with other tes-
tis-speciﬁc genes, was induced in human papillomavirus-positive
cancer cells [30]. TCAM1P may have some functions related both
to cell proliferation and to male meiosis.In any case, the present data provide an important example of
evolutionary changes, especially in gene regulatory mechanisms,
in parallel with pseudogenization.
4.3. Regulation of the SMARCD2-TCAM1P-hGH locus by
multifunctional genomic elements
Finally, it is interesting to note gene regulation by multifunc-
tional genomic elements because the human TCAM1P gene is
linked to the hGH gene cluster. The hGH cluster contains one pitu-
itary-speciﬁc and four placenta-speciﬁc paralogues [31,32], and
their tissue-speciﬁc expression is related to some multifunctional
elements. Firstly, the hGH cluster is controlled by the locus control
region (LCR), which overlaps with the SCN4A gene encoding a
sodium channel protein in the skeletal muscle [12,33,34].
M. Kurihara, A.P. Kimura / FEBS Letters 589 (2015) 540–547 547Secondly, the hGH LCR activates the cluster genes by different
mechanisms between pituitary and placenta [15,16,35–38].
Thirdly, the CD79b gene, which is located between the LCR and
the cluster, functions as a non-coding RNA to activate the hGH-N
gene in the pituitary, but it is translated to a protein in the B cell
[16,39,40]. In addition to these, our current data suggest that a
DPE controls SMARCD2 and TCAM1P gene expression at this locus.
Therefore, the SMARCD2-TCAM1P-hGH locus is a very important
model to study multifunctional genomic elements and tissue-spe-
ciﬁc gene activation.
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